During this time of change Certara support for all software products will continue through normal channels
About Our Software
As the industry leader in quantitative drug development and regulatory science, Certara has pioneered a range of software technologies and platforms to inform and advance the process of bringing drugs to patients. Combining ‘best-of-breed’ legacy brands such as Pharsight®, Simcyp®, Phoenix®, WinNonlin™, Tripos™, Global Submit™, and BaseCase™, Certara’s software is leveraged across the pharma life cycle.
Pharmacologists, biologists, toxicologists, biostatisticians, pre-clinical scientists, chemists, geneticists, and other scientists use our software to advise key safety, efficacy and efficiency decisions. Target identification and optimization, first-in human dose and dosing regimen, translational science, trial design, target validation, compound triaging, comparative efficacy, regulatory submittal, and market access/pricing support are informed by Certara’s growing portfolio of technologies.
Developing new drug therapies and providing them to patients is a complex process. At Certara, we have developed and brought together a unique set of disciplines and technologies to address those underlying factors. More than 1,700 pharma/biotech companies, regulatory institutions, and academic/research entities leverage Certara’s software. Most important, >90 % of all novel FDA approvals have used Certara’s software in the development process, most notably our Phoenix pharmacometrics and Simcyp PBPK platforms. Certara’s software provides benefit across the drug development continuum, from discovery through market access.
The pressure to digitize and disclose clinical information, combined with the ever-growing volume and complexity of data generated in the pharmaceutical development process, have propelled the industry to adopt technology that delivers speed and quality to regulatory submissions. Certara’s regulatory software platforms have been used with hundreds of global submissions, incorporating proven machine learning and artificial intelligence approaches for writing and content reuse, electronic publishing and documentation, and transparency and disclosure of clinical information.
Demonstrating value and the ROI of a new therapy is both an art and a science. Certara’s BaseCase software platform facilitates an all-in-one customer engagement approach to clearly make the value case for that therapy. From value communication tools and calculators, real-world evidence visualizations, KAM and sales training toolkits to innovative pricing tools, e-detailing aids, data tracking, and global HTA and interactive value dossier trackers, BaseCase cloud-based software is the most versatile product of its kind.